Glorify Enterprises Inc Announces Plans to Sell Part of Their Glyconutrients Division
Roanoke, VA (PRWEB) October 21, 2006 -- Glorify Enterprises Inc has announced plans to sell part of their business in the Glyconutrients sector.
Zachary C. Thompson, CEO of Glorify Enterprises, believes the decision to sell part of the Glyconutrients division will put the company in a better position to strengthen their vendor relations and at the same time provide more dedicated service to the company’s existing customers.
The company will sell to a buyer with experience in the nutraceutical industry and a track record of excellent customer service. As a result of making the company a more manageable size, Mr. Thompson believes that Glorify Enterprises will be able to ensure more comprehensive support of company’s distributors and customers throughout the world.
The Glyconutrients division of the company has become one of the world leaders in Glyconutrients e-commerce since launching into this niche market in 2004. Despite selling part of the Glyconutrients division, Mr. Thompson is optimistic that the company will continue to grow rapidly due to a rapidly expanded online marketplace for the Glyconutrients.
Mr. Thompson also stated that Glorify Enterprises Inc expects to finalize the sale of part of their Glyconutrients division by late October of this year. After the sale, Glorify Enterprises will still own about 54% of the Glyconutrients sector of the company.
Glyconutrients are used on the surface of the body’s cells to help with communication between cells and between cells and pathogens. Glyconutrients are finally beginning to be used in mainstream healthcare. A majority of holistic veterinarians in Florida now use Glyconutrients in their respective practices. A search for the term “glycoconjugates” on PubMed now returns over 154,000 research papers.
###